Venous Thromboembolism Devices Market

Posted by ahila on May 1st, 2018

Global Venous Thromboembolism Devices Market :Venous thromboembolism is a disease caused by the clotting of blood in the blood vessel which leads to restriction of blood flow within the circulatory system. It is classified into pulmonary embolism and deep vein thrombosis. Deep vein thrombosis is mainly occurred due to clotting of blood in deep vein (commonly in the leg). The formed DVT clot breaks off and flows to lungs known as pulmonary embolism which is a severe complication of deep vein thrombosis (DVT). Venous thromboembolism commonly occurs in aged persons with more than 60 years. People with overweight, persons with thicker blood and persons suffering from autoimmune disorders such as (lupus, rheumatoid arthritis etc.) or cancer are at higher risk of venous thromboembolism. Venous thromboembolism can cause chronic complications, such as post-thrombotic syndrome (PTS) or chronic thromboembolic pulmonary hypertension (CTEPH). The symptoms associated with the venous thromboembolism include dilated blood veins in legs and chest, oedema, fever, tachycardia, and dyspnoea. Lower extremities are the most common site for DVT, but other locations affected include the mesenteric, upper extremities, pelvic veins, and cerebral veins.

    A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-venous-thromboembolism-devices-market/#ulp-4H8Z4LpNMLEuOnn

The venous thromboembolism devices market is growing at a significant CAGR due to increase in geriatric population. Rise in government expenditure, increasing incidence of venous thromboembolism, and high unmet needs of currently available treatment procedures are fuelling the venous thromboembolism devices market. For instance, in 2014 May, U.S. FDA issued post market surveillance study for inferior vena cava filters which provides information regarding implementation of the filters and risks of pulmonary thromboembolism. Furthermore, increase in surgical procedures such as hip and knee replacements that are risk factors for venous thromboembolism conditions. Growing patient awareness regarding venous thromboembolism conditions expected to boost the venous thromboembolism devices market over the forecast period.  However, high cost of deep vein thrombosis treatment, difficult pathophysiology of the venous thromboembolism hinders the growth of venous thromboembolism devices market. Similarly, stringent regulatory approvals for the development of products are expected to dampen growth of venous thromboembolism devices market over the forecast period.

The venous thromboembolism devices market is segmented on the basis of product type, disease type, and end user

Based on type of device, venous thromboembolism devices market is segmented into the following

• Compression Stockings
• Gradual or medical compression stockings
• Anti-embolism stockings
• Nonmedical support hosiery
• Intermitted pneumatic compression devices
• Inferior vena cava filters
• Retrievable IVC filters
• Permanent IVC Filters

Based on disease type, the venous thromboembolism devices market is segmented into the following

• Deep vein thrombosis
• Pulmonary embolism

Based on end-user, the venous thromboembolism devices market is segmented into the following

• Hospitals
• Diagnostic centres
• Ambulatory surgical centres

   To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-venous-thromboembolism-devices-market/#ulp-c654SbFYO64MsOhu